Page last updated: 2024-08-16

repirinast and my 1250

repirinast has been researched along with my 1250 in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (50.00)	18.7374
1990's	5 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beermann, D; Heibel, B; Kuhlmann, J; Schaefer, HG; Sturm, Y; Wargenau, M	1
Kadowaki, S; Takahashi, K; Umezu, K; Yamada, N	1
Endo, K; Takahashi, K; Takei, M	2
Arai, Y; Endoh, K; Takahashi, K; Yamada, N	1
Shono, T; Takahashi, K	1
Endoh, K; Takahashi, K; Yamada, N; Yasumura, K	1
Kohno, SW; Ohata, K	1
Hanazuka, M; Hara, Y; Horii, D; Nishi, H	1
Arai, Y; Funayama, K; Kadowaki, S; Takahashi, K; Umezu, K; Yamada, N	1

Trials

1 trial(s) available for repirinast and my 1250

Article	Year
Pharmacokinetics of the active metabolite of the prodrug repirinast in healthy Caucasian volunteers after a single oral dose. European journal of clinical pharmacology, 1992, Volume: 42, Issue:3 Topics: Administration, Oral; Analysis of Variance; Chromatography, High Pressure Liquid; Double-Blind Method; Humans; Male; Prodrugs; Quinolones; Reference Values; Reproducibility of Results; White People	1992

Article

Year

Pharmacokinetics of the active metabolite of the prodrug repirinast in healthy Caucasian volunteers after a single oral dose.

European journal of clinical pharmacology, 1992, Volume: 42, Issue:3

Topics: Administration, Oral; Analysis of Variance; Chromatography, High Pressure Liquid; Double-Blind Method; Humans; Male; Prodrugs; Quinolones; Reference Values; Reproducibility of Results; White People

1992

Other Studies

9 other study(ies) available for repirinast and my 1250

Article	Year
MY-1250, a major metabolite of the anti-allergic drug repirinast, induces phosphorylation of a 78-kDa protein in rat mast cells. Biochemical pharmacology, 1992, Sep-25, Volume: 44, Issue:6 Topics: Animals; Calcimycin; Drug Interactions; Histamine Antagonists; Histamine H1 Antagonists; Male; Mast Cells; Phosphorylation; Proteins; Quinolones; Rats; Rats, Wistar	1992
Mechanism of action of MY-1250, an active metabolite of Repirinast, in inhibiting histamine release from rat mast cells. British journal of pharmacology, 1992, Volume: 105, Issue:3 Topics: Adenosine Triphosphate; Animals; Ascaris; Calcium; Cyclic AMP; Histamine Antagonists; Histamine H1 Antagonists; Histamine Release; In Vitro Techniques; Male; Mast Cells; Passive Cutaneous Anaphylaxis; Peritoneal Cavity; Quinolones; Rats; Rats, Inbred Strains	1992
Inhibition of histamine release from rat peritoneal mast cells by MY-1250, an active metabolite of Repirinast (MY-5116). International archives of allergy and applied immunology, 1990, Volume: 93, Issue:2-3 Topics: Animals; Calcium; Cromolyn Sodium; Histamine H1 Antagonists; Histamine Release; Male; Mast Cells; Quinolones; Rats; Rats, Inbred Strains	1990
[Inhibitory effect on the release of mediators from rat peritoneal exudate cells and the antagonistic effect against mediators of MY-5116 and other anti-allergic agents]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1986, Volume: 88, Issue:3 Topics: Animals; Bradykinin; Chromones; Cromolyn Sodium; Female; Guinea Pigs; Histamine H1 Antagonists; Hypersensitivity; Ketotifen; Male; Muscle, Smooth; ortho-Aminobenzoates; Passive Cutaneous Anaphylaxis; Peritoneal Cavity; Quinolines; Quinolones; Rats; Serotonin Antagonists; SRS-A	1986
[Effects of MY-1250, a main active metabolite of MY-5116, a new anti-allergic drug, on histamine release from monkey lung fragments]. Arerugi = [Allergy], 1986, Volume: 35, Issue:9 Topics: Animals; Female; Guinea Pigs; Histamine H1 Antagonists; Histamine Release; Immunoglobulin E; In Vitro Techniques; Lung; Macaca fascicularis; Male; Quinolines; Quinolones	1986
Effects of MY-1250, a main active metabolite of MY-5116, a new anti-allergic agent, on the release of mediators from guinea pig lung fragments. Arerugi = [Allergy], 1986, Volume: 35, Issue:9 Topics: Animals; Female; Guinea Pigs; Histamine H1 Antagonists; Histamine Release; In Vitro Techniques; Lung; Quinolines; Quinolones; SRS-A	1986
[Antiallergic effect of MY-5116 and its major metabolite, MY-1250]. Arerugi = [Allergy], 1986, Volume: 35, Issue:11 Topics: Animals; Female; Guinea Pigs; Histamine Antagonists; Histamine H1 Antagonists; Histamine Release; Humans; In Vitro Techniques; Lung; Quinolines; Quinolones; Rats; SRS-A	1986
[Cardiovascular effects of MY-5116 and MY-1250]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1986, Volume: 87, Issue:4 Topics: Animals; Arteries; Blood Pressure; Cardiovascular System; Cromolyn Sodium; Dogs; Electrocardiography; Female; Ganglia, Sympathetic; Guinea Pigs; Heart Rate; Immunosuppressive Agents; Male; Nictitating Membrane; Quinolines; Quinolones; Rats; Rats, Inbred Strains; Respiration	1986
Effect of a major metabolite of the antiallergic drug repirinast on phosphodiesterase and adenylate cyclase activities. Arzneimittel-Forschung, 1995, Volume: 45, Issue:1 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclase Inhibitors; Animals; Colforsin; Cromolyn Sodium; Exudates and Transudates; Histamine H1 Antagonists; Histamine Release; In Vitro Techniques; Lung; Male; Peritoneal Cavity; Phosphodiesterase Inhibitors; Quinolones; Rats; Rats, Wistar; Theophylline	1995